Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Pablo Berlanga"'
Autor:
Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, Robin Droit, Wan Ching Lim, Antonin Marchais, Jerome Salmon, Sarah Cherkaoui, Raphael J. Morscher, Anouchka Laurent, Sébastien Malinge, Thomas Mercher, Séverine Tabone-Eglinger, Isabelle Goddard, Francoise Pflumio, Julien Calvo, Francoise Redini, Natacha Entz-Werlé, Aroa Soriano, Alberto Villanueva, Stefano Cairo, Pascal Chastagner, Massimo Moro, Cormac Owens, Michela Casanova, Raquel Hladun-Alvaro, Pablo Berlanga, Estelle Daudigeos-Dubus, Philippe Dessen, Laurence Zitvogel, Ludovic Lacroix, Gaelle Pierron, Olivier Delattre, Gudrun Schleiermacher, Didier Surdez, Birgit Geoerger
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-15 (2023)
Abstract Pediatric patients with recurrent and refractory cancers are in most need for new treatments. This study developed patient-derived-xenograft (PDX) models within the European MAPPYACTS cancer precision medicine trial (NCT02613962). To date, 1
Externí odkaz:
https://doaj.org/article/0bccef955fcd4460a5c66a0d211aaac0
Autor:
Anne-Laure Genevois, Matthieu Carton, Myriam Jean-Denis, Joanna Cyrta, Nadège Corradini, Pablo Berlanga, Claire Chemin-Airiau, Charles Honore, Sophie El Zein, Anne-Sophie Defachelles, Emmanuelle Bompas, Philippe Anract, Justine Gantzer, Marie Karanian, Angélique Rome, Florence Duffaud, Christine Chevreau, Sarah Watson, Axel Le Cesne, Carmen Llacer, François Le Loarer, Gaëlle Pierron, François Gouin, Anne Gomez-Mascard, Sylvain Causeret, Françoise Ducimetière, Elsa Kalbacher, Maud Toulmonde, Jean-Yves Blay, Daniel Orbach
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100026- (2023)
Background: Leiomyosarcoma (LMS) and liposarcoma (LPS) are ultra-rare sarcomas in pediatric (0–18 years) and young adult (19−30) populations. We aimed to analyze their clinical characteristics at these young ages and to determine whether they sho
Externí odkaz:
https://doaj.org/article/ce7c19a233f041e78e3deea7fa01d9cf
Autor:
Monika Sparber‐Sauer, Nadège Corradini, Maria Carmen Affinita, Giuseppe Maria Milano, Gaelle Pierron, Matthieu Carton, Franck Tirode, Daniel Pissaloux, Rita Alaggio, Christian Vokuhl, Gianni Bisogno, Pablo Berlanga, Andrea Ferrari, Daniel Orbach
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14346-14359 (2023)
Abstract Background In certain rare undifferentiated small round cell sarcomas new specific molecular CIC‐DUX4/other partner, BCOR‐CCNB3/other partner, YWHAE fusions, or BCOR‐ITD (internal tandem duplication) were identified. These new “CIC f
Externí odkaz:
https://doaj.org/article/dea8e6b5df8a41f89a769d74263b53f3
Autor:
Jordane Chaix, Marie Karanian, Nadège Corradini, Maria Merched, Frédérique Larousserie, Louise Galmiche, Brigitte Lacour, Aude Marie-Cardine, Anne-Sophie Defachelles, Pablo Berlanga, Angélique Rome, Estelle Thébaud, Valérie Bernier-Chastagner, Hervé J. Brisse, Frédéric Hameury, Pierre Wolkenstein, Stéphane Ducassou, Daniel Orbach, Cécile Vérité
Publikováno v:
EJC Paediatric Oncology, Vol 1, Iss , Pp 100013- (2023)
Introduction: Malignant Peripheral Nerve Sheath Tumors (MPNST) are very rare and aggressive tumors, which can affect children, adolescents, and young adults. These tumors are frequently associated with type 1 neurofibromatosis (NF1). This study aims
Externí odkaz:
https://doaj.org/article/f3151756ad4b4376942cc0267aae768d
Autor:
Arthur Felix, Pablo Berlanga, Maud Toulmonde, Judith Landman‐Parker, Sarah Dumont, Gilles Vassal, Marie‐Cécile Le Deley, Nathalie Gaspar
Publikováno v:
Cancer Medicine, Vol 10, Iss 5, Pp 1589-1604 (2021)
Abstract Background Optimal Phase‐II design to evaluate new therapies in refractory/relapsed Ewing sarcomas (ES) remains imperfectly defined. Objectives Recurrent/refractory ES phase‐I/II trials analysis to improve trials design. Methods Comprehe
Externí odkaz:
https://doaj.org/article/b6c7f503d5e0493b98b803fc267a35b3
Autor:
Andrea Urtasun, Gladys G. Olivera, Luis Sendra, Salvador F. Aliño, Pablo Berlanga, Pablo Gargallo, David Hervás, Julia Balaguer, Antonio Juan-Ribelles, María del Mar Andrés, Adela Cañete, María José Herrero
Publikováno v:
Cancers, Vol 15, Iss 5, p 1424 (2023)
Background: Pharmacogenetics is a personalized medicine tool that aims to optimize treatments by adapting them to each individual’s genetics, maximizing their efficacy while minimizing their toxicity. Infants with cancer are especially vulnerable,
Externí odkaz:
https://doaj.org/article/6b4044fc3f064f83a27c881d8e61f0f7
Autor:
Giulia Del Sindaco, Pablo Berlanga, Laurence Brugières, Eric Thebault, Giovanna Mantovani, Philippe Wicart, Agnès Linglart
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated with open surgery, but there is more and more a
Externí odkaz:
https://doaj.org/article/5ecff5de04874af9b45e5ddafa758ddc
Autor:
Pablo Gargallo, Jaime Font de Mora, Pablo Berlanga, Inés Calabria, Margarita Llavador, Laia Pedrola, Joaquín Panadero, Sandra Dolz, Ángel Zúñiga, Juan Silvestre Oltra, Paloma Escobar, Yania Yáñez, María José Aparisi, Marina Martinez-Matilla, Vanessa Segura, Carlos Esquembre, María Del Cañizo, María José Moreno, Catalina Márquez, Adela Cañete, Victoria Castel
Publikováno v:
Translational Medicine Communications, Vol 4, Iss 1, Pp 1-11 (2019)
Abstract Background Understanding pediatric cancer biology is a huge challenge in continuous development that is currently being implemented into the clinical practice thanks to the new high throughput technologies integrated by personalized medicine
Externí odkaz:
https://doaj.org/article/450f5e23d5b04eedb8440b7f871920b8
Autor:
Gladys G. Olivera, Andrea Urtasun, Luis Sendra, Salvador F. Aliño, Yania Yáñez, Vanessa Segura, Pablo Gargallo, Pablo Berlanga, Victoria Castel, Adela Cañete, María José Herrero
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 9815 (2021)
Pharmacogenetics is one of the cornerstones of Personalized Precision Medicine that needs to be implemented in the routine of our patients’ clinical management in order to tailor their therapies as much as possible, with the aim of maximizing effic
Externí odkaz:
https://doaj.org/article/a9d908f604834a96b61ab68f587d52cc
Autor:
Antonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, Vanessa Segura, Yania Yáñez, Bárbara Juan, Marta Salom, Margarita Llavador, Jaime Font de Mora, Victoria Castel, Adela Cañete
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 4, p 268 (2021)
Background: Bone and soft-tissue sarcomas represent 13% of all paediatric malignancies. International contributions to introduce next-generation sequencing (NGS) approaches into clinical application are currently developing. We present the results fr
Externí odkaz:
https://doaj.org/article/7766472dd96248638860e5f878e43c7e